161 Recruiting Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Lymphoma
Related Conditions
Top Recruiting Lymphoma Studies
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
View Study & Checklist ➔Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
View Study & Checklist ➔A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
📍 Northwestern University (Data Collection Only) — Evanston, Illinois
View Study & Checklist ➔A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
📍 Stanford Cancer Institute — Stanford, California
View Study & Checklist ➔A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Axi-cel in CNS Lymphoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
View Study & Checklist ➔Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
📍 Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔GLORY: Glofit-GemOx With Liso-Cel For Lymphoma
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Navigating the Clinical Research Process for Lymphoma
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
📍 Mass General Hospital — Boston, Massachusetts
View Study & Checklist ➔CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
📍 Texas Children's Hospital — Houston, Texas
View Study & Checklist ➔A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
📍 University Of Colorado — Aurora, Colorado
View Study & Checklist ➔Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
📍 Stanford Medicine Cancer Center — Palo Alto, California
View Study & Checklist ➔Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
📍 Mass General Brigham — Boston, Massachusetts
View Study & Checklist ➔Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
📍 Columbia University — New York, New York
View Study & Checklist ➔AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
📍 Research Site — Duarte, California
View Study & Checklist ➔